Although most of the literature provides evidence that T2D symptoms improve with MPC loss in skeletal muscle and liver, there are a few studies that report opposing changes associated with MPC alterations or studies that have utilized mice heterozygous for either full-body Mpc1 or Mpc2 deletion. The gene discussed is MPC2; the disease is type 2 diabetes mellitus.